Protein aggregation is a hallmark of a number of neurodegenerative diseases. While different diseases are associated with the accumulation of distinct proteins, the process of aggregation from the formation of oligomers to protofibrils to mature aggregates is similar. In a recent review, Soto and Pritzkow discuss these similarities and the process by which protein aggregates are transmissible. Transmission of protein aggregates can be described using the seeding‑nucleation model in which pre‑formed aggregates or “seeds” recruit normal proteins into the aggregate. Aggregates can also undergo fragmentation releasing more seeds which can spread from cell‑to‑cell or brain region‑to‑region, similar to the process of Prion infection.

To study the process of protein aggregation in neurodegeneration, BioLegend offers several clones that are specific to aggregate or fibril forms of proteins associated with neurodegenerative diseases including β‑Amyloid and α‑Synuclein.
Adapted from Soto and Prtizkow, 2018. Nature Neuroscience. 21‑1332‑1340. Pubmed.
Description Clone
α‑Synuclein, aggregated Syn‑O2
Amyloid Fibril (pan reactive) B10AP
β‑Amyloid, 1‑15 3A1
β‑Amyloid, aggregated A17171C
Transthyretin, aggregated 2T5C9
Learn more about our new β‑Amyloid aggregate‑preferring clone, 3A1!
If you're interested in Neurodegenerative diseases, check out our new Neurodegeneration Brochure highlighting our antibodies, recombinant proteins, and ELISA kits against key targets involved in Neurodegeneration including Tau, α‑Synuclein, and β‑Amyloid. 


*Any references to promotions on this page may not be valid at this time. View our promotions page for the most up-to-date promotions.
Insert Note Here
Save Close Clear
Lab Timer
Remember me
Forgot your password? Reset Password
Request an Account